[非结核菌:诊断挑战和个性化治疗方法]
Elena Terhalle1, Jessica Rademacher1,2
1Pneumologie Süderelbe, Facharztpraxis für Pneumologie, Infektiologie und Allergologie, Hamburg.
Deutsche medizinische Wochenschrift (1946)
|October 28, 2025
概括
非结核菌 (NTM) 肺部疾病正在上升,特别是在结核病发病率较低的地区. 诊断需要临床,放射和微生物学证据,治疗是复杂和个性化的.
科学领域:
- 肺部医学 肺部医学
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 非结核性真菌菌 (NTM) 正在成为重要的病原体.
- 由NTM (NTM-PD) 引起的肺病显示每年持续增加.
- 风险因素包括结构性肺部疾病,免疫缺陷和免疫抑制疗法.
研究的目的:
- 审查当前的证据,并为管理NTM-PD提供实际建议.
- 突出诊断挑战和新兴工具.
- 讨论NTM-PD的复杂治疗策略.
主要方法:
- 审查关于NTM-PD诊断和管理的当前文献.
- 对NTM-PD趋势的流行病学数据的分析.
- 讨论新的诊断方法和已确定的治疗指南.
主要成果:
- NTM-PD的发病率正在上升,超过一半的隔离物与真正的疾病有关.
- 诊断依赖于临床,放射学和微生物学的发现.
- 唾液培养对于物种识别和药物敏感性测试至关重要.
- 新型诊断显示出有希望,但唾液培养仍然是必不可少的.
- 治疗是物种特异性的,宏类是基础的,吸入的脂质体阿米卡辛有助于耐火MAC疾病.
结论:
- 管理NTM-PD需要一个多学科的方法.
- 必须制定个性化治疗策略,平衡疗效和耐受性.
- 定期监测对于NTM-PD的成功结果至关重要.
- 对新型诊断和治疗的进一步研究是有必要的.
相关概念视频
Pulmonary Tuberculosis IV
472
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
472
Pulmonary Tuberculosis V
532
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
532
Pulmonary Tuberculosis III
921
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
921
Pulmonary Tuberculosis I
820
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
820
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Therapeutic Drug Monitoring: Affecting Factors
196
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
196


